Clinical Trial Update: NHFOV vs. NCPAP as a Primary Treatment to Neonatal Respiratory Distress Syndrome(NRDS) [NA]

View source ↗

Summary

Clinical trial update comparing NHFOV and NCPAP as primary treatment for neonatal respiratory distress syndrome in preterm infants; trial completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Respiratory Distress Syndrome
• Preterm Infant Complications

Snippet

Sponsor: Xingwang Zhu | Conditions: Preterm Infants | NA | Status: COMPLETED | Results posted: 2019-06-10